Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1999 Oct;54(10):911–916. doi: 10.1136/thx.54.10.911

Increased levels of interleukin-16 in the airways of tobacco smokers: relationship with peripheral blood T lymphocytes

M Laan 1, I Qvarfordt 1, G Riise 1, B Andersson 1, S Larsson 1, A Linden 1
PMCID: PMC1745375  PMID: 10491454

Abstract

BACKGROUND—The mechanisms behind the development of systemic immunomodulation among tobacco smokers are not fully understood, but several studies have indicated a role for CD8+ and/or CD4+ T cells. Interleukin (IL)-16, a cytokine released from inflammatory cells as well as bronchial epithelial cells, can recruit and activate CD4+ T cells. A study was undertaken to establish whether the IL-16 level is increased in the airways of tobacco smokers and to determine whether airway levels of IL-16 are related to the number and function of systemic T lymphocytes.
METHODS—Bronchoalveolar lavage (BAL) fluid was collected from eight never smokers and 18 tobacco smokers without clinical airway symptoms, and from 16 tobacco smokers with clinical airway symptoms. Interleukin-16 protein levels in BAL fluid were determined using enzyme-linked immunosorbent assay (ELISA). Peripheral blood was collected for determination of CD4+ T cell content using flow cytometry. The responsiveness of systemic lymphocytes in smokers was assessed by measuring the proliferative response of peripheral blood lymphocytes to the superantigen staphylococcus enterotoxin A (SEA).
RESULTS—The IL-16 protein level in the BAL fluid was significantly higher in tobacco smokers than in non-smokers. However, among tobacco smokers the IL-16 level was similar in asymptomatic smokers and in those with airway symptoms. The level of IL-16 in the BAL fluid of smokers correlated negatively with the percentage of CD4+ T cells and positively with superantigen stimulated lymphocyte proliferation in peripheral blood.
CONCLUSIONS—In tobacco smokers the airway IL-16 level is increased and it is possible that this increase in IL-16 influences systemic immunomodulation by altering the number and responsiveness of systemic T lymphocytes.



Full Text

The Full Text of this article is available as a PDF (83.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aronson M. D., Weiss S. T., Ben R. L., Komaroff A. L. Association between cigarette smoking and acute respiratory tract illness in young adults. JAMA. 1982 Jul 9;248(2):181–183. [PubMed] [Google Scholar]
  2. Bellini A., Yoshimura H., Vittori E., Marini M., Mattoli S. Bronchial epithelial cells of patients with asthma release chemoattractant factors for T lymphocytes. J Allergy Clin Immunol. 1993 Sep;92(3):412–424. doi: 10.1016/0091-6749(93)90120-5. [DOI] [PubMed] [Google Scholar]
  3. Boman G., Bäcker U., Larsson S., Melander B., Wåhlander L. Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases. Eur J Respir Dis. 1983 Aug;64(6):405–415. [PubMed] [Google Scholar]
  4. Burrows B., Halonen M., Barbee R. A., Lebowitz M. D. The relationship of serum immunoglobulin E to cigarette smoking. Am Rev Respir Dis. 1981 Nov;124(5):523–525. doi: 10.1164/arrd.1981.124.5.523. [DOI] [PubMed] [Google Scholar]
  5. Burrows B., Lebowitz M. D., Barbee R. A. Respiratory disorders and allergy skin-test reactions. Ann Intern Med. 1976 Feb;84(2):134–139. doi: 10.7326/0003-4819-84-2-134. [DOI] [PubMed] [Google Scholar]
  6. Center D. M., Cruikshank W. Modulation of lymphocyte migration by human lymphokines. I. Identification and characterization of chemoattractant activity for lymphocytes from mitogen-stimulated mononuclear cells. J Immunol. 1982 Jun;128(6):2563–2568. [PubMed] [Google Scholar]
  7. Cruikshank W. W., Kornfeld H., Center D. M. Signaling and functional properties of interleukin-16. Int Rev Immunol. 1998;16(5-6):523–540. doi: 10.3109/08830189809043007. [DOI] [PubMed] [Google Scholar]
  8. Cruikshank W. W., Lim K., Theodore A. C., Cook J., Fine G., Weller P. F., Center D. M. IL-16 inhibition of CD3-dependent lymphocyte activation and proliferation. J Immunol. 1996 Dec 15;157(12):5240–5248. [PubMed] [Google Scholar]
  9. Cruikshank W. W., Long A., Tarpy R. E., Kornfeld H., Carroll M. P., Teran L., Holgate S. T., Center D. M. Early identification of interleukin-16 (lymphocyte chemoattractant factor) and macrophage inflammatory protein 1 alpha (MIP1 alpha) in bronchoalveolar lavage fluid of antigen-challenged asthmatics. Am J Respir Cell Mol Biol. 1995 Dec;13(6):738–747. doi: 10.1165/ajrcmb.13.6.7576712. [DOI] [PubMed] [Google Scholar]
  10. Fournier M., Lebargy F., Le Roy Ladurie F., Lenormand E., Pariente R. Intraepithelial T-lymphocyte subsets in the airways of normal subjects and of patients with chronic bronchitis. Am Rev Respir Dis. 1989 Sep;140(3):737–742. doi: 10.1164/ajrccm/140.3.737. [DOI] [PubMed] [Google Scholar]
  11. Freedman D. S., Flanders W. D., Barboriak J. J., Malarcher A. M., Gates L. Cigarette smoking and leukocyte subpopulations in men. Ann Epidemiol. 1996 Jul;6(4):299–306. doi: 10.1016/s1047-2797(96)00024-5. [DOI] [PubMed] [Google Scholar]
  12. Geiselhart L. A., Christian T., Minnear F., Freed B. M. The cigarette tar component p-benzoquinone blocks T-lymphocyte activation by inhibiting interleukin-2 production, but not CD25, ICAM-1, or LFA-1 expression. Toxicol Appl Pharmacol. 1997 Mar;143(1):30–36. doi: 10.1006/taap.1996.8071. [DOI] [PubMed] [Google Scholar]
  13. Geng Y., Savage S. M., Razani-Boroujerdi S., Sopori M. L. Effects of nicotine on the immune response. II. Chronic nicotine treatment induces T cell anergy. J Immunol. 1996 Apr 1;156(7):2384–2390. [PubMed] [Google Scholar]
  14. Gerrard J. W., Heiner D. C., Ko C. G., Mink J., Meyers A., Dosman J. A. Immunoglobulin levels in smokers and non-smokers. Ann Allergy. 1980 May;44(5):261–262. [PubMed] [Google Scholar]
  15. Hessel E. M., Cruikshank W. W., Van Ark I., De Bie J. J., Van Esch B., Hofman G., Nijkamp F. P., Center D. M., Van Oosterhout A. J. Involvement of IL-16 in the induction of airway hyper-responsiveness and up-regulation of IgE in a murine model of allergic asthma. J Immunol. 1998 Mar 15;160(6):2998–3005. [PubMed] [Google Scholar]
  16. Laberge S., Ernst P., Ghaffar O., Cruikshank W. W., Kornfeld H., Center D. M., Hamid Q. Increased expression of interleukin-16 in bronchial mucosa of subjects with atopic asthma. Am J Respir Cell Mol Biol. 1997 Aug;17(2):193–202. doi: 10.1165/ajrcmb.17.2.2750. [DOI] [PubMed] [Google Scholar]
  17. Lams B. E., Sousa A. R., Rees P. J., Lee T. H. Immunopathology of the small-airway submucosa in smokers with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 1):1518–1523. doi: 10.1164/ajrccm.158.5.9802121. [DOI] [PubMed] [Google Scholar]
  18. O'Shaughnessy T. C., Ansari T. W., Barnes N. C., Jeffery P. K. Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. Am J Respir Crit Care Med. 1997 Mar;155(3):852–857. doi: 10.1164/ajrccm.155.3.9117016. [DOI] [PubMed] [Google Scholar]
  19. Parada N. A., Center D. M., Kornfeld H., Rodriguez W. L., Cook J., Vallen M., Cruikshank W. W. Synergistic activation of CD4+ T cells by IL-16 and IL-2. J Immunol. 1998 Mar 1;160(5):2115–2120. [PubMed] [Google Scholar]
  20. Petersen B. H., Steimel L. F., Callaghan J. T. Suppression of mitogen-induced lymphocyte transformation in cigarette smokers. Clin Immunol Immunopathol. 1983 Apr;27(1):135–140. doi: 10.1016/0090-1229(83)90062-4. [DOI] [PubMed] [Google Scholar]
  21. Prescott E., Osler M., Andersen P. K., Hein H. O., Borch-Johnsen K., Lange P., Schnohr P., Vestbo J. Mortality in women and men in relation to smoking. Int J Epidemiol. 1998 Feb;27(1):27–32. doi: 10.1093/ije/27.1.27. [DOI] [PubMed] [Google Scholar]
  22. Qvarfordt I., Riise G. C., Larsson S., Almqvist G., Rollof J., Bengtsson T., Andersson B. A. Immunological findings in blood and bronchoalveolar lavage fluid in chronic bronchitis patients with recurrent infectious exacerbations. Eur Respir J. 1998 Jan;11(1):46–54. doi: 10.1183/09031936.98.11010046. [DOI] [PubMed] [Google Scholar]
  23. Rand T. H., Cruikshank W. W., Center D. M., Weller P. F. CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration. J Exp Med. 1991 Jun 1;173(6):1521–1528. doi: 10.1084/jem.173.6.1521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Saetta M., Di Stefano A., Maestrelli P., Ferraresso A., Drigo R., Potena A., Ciaccia A., Fabbri L. M. Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am Rev Respir Dis. 1993 Feb;147(2):301–306. doi: 10.1164/ajrccm/147.2.301. [DOI] [PubMed] [Google Scholar]
  25. Saetta M., Turato G., Facchini F. M., Corbino L., Lucchini R. E., Casoni G., Maestrelli P., Mapp C. E., Ciaccia A., Fabbri L. M. Inflammatory cells in the bronchial glands of smokers with chronic bronchitis. Am J Respir Crit Care Med. 1997 Nov;156(5):1633–1639. doi: 10.1164/ajrccm.156.5.9701081. [DOI] [PubMed] [Google Scholar]
  26. Sopori M. L., Kozak W. Immunomodulatory effects of cigarette smoke. J Neuroimmunol. 1998 Mar 15;83(1-2):148–156. doi: 10.1016/s0165-5728(97)00231-2. [DOI] [PubMed] [Google Scholar]
  27. Standardized lung function testing. Report working party. Bull Eur Physiopathol Respir. 1983 Jul;19 (Suppl 5):1–95. [PubMed] [Google Scholar]
  28. Tollerud D. J., Clark J. W., Brown L. M., Neuland C. Y., Mann D. L., Pankiw-Trost L. K., Blattner W. A., Hoover R. N. The effects of cigarette smoking on T cell subsets. A population-based survey of healthy caucasians. Am Rev Respir Dis. 1989 Jun;139(6):1446–1451. doi: 10.1164/ajrccm/139.6.1446. [DOI] [PubMed] [Google Scholar]
  29. Van Epps D. E., Potter J. W., Durant D. A. Production of a human T lymphocyte chemotactic factor by T cell subpopulations. J Immunol. 1983 Jun;130(6):2727–2731. [PubMed] [Google Scholar]
  30. Wewers M. D., Diaz P. T., Wewers M. E., Lowe M. P., Nagaraja H. N., Clanton T. L. Cigarette smoking in HIV infection induces a suppressive inflammatory environment in the lung. Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 1):1543–1549. doi: 10.1164/ajrccm.158.5.9802035. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES